Platelet and neutrophil to lymphocyte ratios predict survival in patients with resectable colorectal liver metastases

Am J Surg. 2020 Dec;220(6):1579-1585. doi: 10.1016/j.amjsurg.2020.05.003. Epub 2020 May 14.

Abstract

Background: The prognostic significance of the platelet (PLR) and neutrophil (NLR) to lymphocyte ratios for patients with resectable colorectal cancer liver metastases (CLM) was evaluated.

Methods: Clinicopathologic data from patients who underwent hepatectomy for CLM at two tertiary care hospitals between 1995 and 2017 were collected. Blood counts were evaluated for prognostic significance.

Results: 151 patients met inclusion criteria. The median age was 58 years, 44% were female, and 58% had synchronous metastases. Median number of liver metastases was 2, and 59% of patients underwent lobectomy or extended lobectomy. On multivariable analysis, NLR ≥5 (HR 2.46 [1.08-5.60 CI], p = 0.032), PLR ≥ 220 (HR 2.10 [1.04-4.23 CI], p = 0.037), and greater than 2 liver metastases (HR 2.41 [1.06-5.45 CI], p = 0.035) were associated with reduced overall survival.

Conclusions: PLR ≥ 220 and NLR ≥ 5 may have utility as preoperative prognostic markers for overall survival in patients with resectable CLM.

Keywords: Colorectal; Hepatectomy; Liver metastasis; Neutrophil-to-lymphocyte ratio; Overall survival; Platelet-to-lymphocyte ratio; Prognosis.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Colorectal Neoplasms / blood*
  • Colorectal Neoplasms / mortality*
  • Colorectal Neoplasms / pathology
  • Female
  • Hepatectomy
  • Humans
  • Leukocyte Count
  • Liver Neoplasms / blood*
  • Liver Neoplasms / mortality*
  • Liver Neoplasms / secondary
  • Liver Neoplasms / surgery
  • Lymphocytes*
  • Male
  • Middle Aged
  • Neutrophils*
  • Platelet Count
  • Predictive Value of Tests
  • Prognosis
  • Retrospective Studies